Search the Newsreel

Immunome Inc. Q2 2026: Revenue $0 Net loss $73.1M, EPS $(0.65) — 10-Q Summary

Immunome Inc. reported Q2 2026 financial results, showing zero revenue and a net loss of $73.1 million, or $(0.65) per diluted share. This is a decline compared to the prior year's Q2 2025, which had $4 million in revenue and a net loss of …

Nomad Foods earnings in spotlight as Europe frozen food leader pivots

Nomad Foods is scheduled to release its second-quarter results, with investors keenly observing whether the frozen food company can meet its recently increased guidance and demonstrate progress in its operational turnaround. Analysts anticipate earnings of €0.33 per share on revenue of €710.9 million, indicating …

These Analysts Think Metagenomi Therapeutics, Inc.'s (NASDAQ:MGX) Sales Are Under Threat

Analysts have significantly cut their revenue and increased their loss per share estimates for Metagenomi Therapeutics, Inc. (NASDAQ:MGX) for 2026. The new consensus predicts a substantial 43% decline in revenue and increased losses per share compared to previous forecasts. This revision suggests a more …

US$49.54 - That's What Analysts Think 10x Genomics, Inc. (NASDAQ:TXG) Is Worth After These Results

Williams-Sonoma (WSM) Receives a Hold from Wells Fargo

Williams-Sonoma (WSM) Receives a Buy from Goldman Sachs

Handelsbanken Fonder AB Purchases 10,965 Shares of Williams-Sonoma, Inc. $WSM

Handelsbanken Fonder AB increased its stake in Williams-Sonoma, Inc. (NYSE:WSM) by 8.1% in the second quarter, acquiring an additional 10,965 shares. This raised their total holdings to 146,185 shares, valued at approximately $34.08 million. Other institutional investors also adjusted their positions in the company, …

Renaissance Technologies LLC Acquires New Shares in NeoGenomics, Inc. $NEO

Renaissance Technologies LLC has acquired 254,172 shares of NeoGenomics, Inc. (NASDAQ:NEO) worth approximately $1.89 million, increasing institutional ownership of the company to 98.5%. This comes as NeoGenomics exceeded Q1 earnings expectations with $0.05 EPS and $201.66 million in revenue, an 11.2% year-over-year increase. Analysts …

FRNM | Freenome, Inc. Common stock Stock Data, Price & News

This page provides comprehensive data for Freenome, Inc. (FRNM) Common Stock, covering real-time price, financials, forecasts, insider and institutional holdings, and news. It details information on corporate lobbying, revenue breakdowns, U.S. patents, government contracts, and analyst ratings. The platform also offers tools for tracking …

Saudi PIF-backed Emaar Economic City posts $5.87mln net loss in Q2 2026

Nomura Securities and other entities have filed a change in shareholding report for Tokai Carbon, reflecting a decrease in the stake (10.50%→10.44%).

Nomura Securities and related entities have submitted a change in shareholding report for Tokai Carbon. The report indicates a slight decrease in their collective stake in the company, moving from 10.50% to 10.44%.

Trading Systems Reacting to (NOMD) Volatility

This article analyzes Nomad Foods Limited (NASDAQ: NOMD) volatility using AI models, identifying near-term and long-term weak sentiment despite a neutral mid-term outlook. It presents three institutional trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss levels. The …

Williams-Sonoma Inc (WSM) carries 49.3% 12-week advance into latest weekly close

The home-products retailer remains in an active trend, while volume signals are less uniform than the price action.

Fomento Economico Mexicano S.A. (FMX) Stock Forecasts

Technical Reactions to NEO Trends in Macro Strategies

This article provides a technical analysis of Neogenomics Inc. (NYSE: NEO) based on AI models, indicating strong sentiment across all time horizons and compelling upside potential. It outlines three distinct trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss …

Bionano Genomics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:BNGO)

Bionano Genomics, Inc. published its 2026 Q2 earnings call presentation. The slide deck was released in conjunction with the company's Q2 earnings call. This article was written by SA Transcripts, which publishes thousands of quarterly earnings call transcripts.

Armanino Foods of Distinction Inc. (AMNF) Q2 Earnings and Revenues Top Estimates

Armanino Foods of Distinction Inc. (AMNF) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.15 per share a year ago. These figures are adjusted for non-recurring items. This quarterly …

Immunome Q2 Results: EPS Misses Estimate, Losses Widen 30% YoY

Immunome Inc. reported a Q2 2026 net loss of $73.1 million, significantly wider than the previous year, primarily due to increased R&D and administrative expenses, and missed EPS estimates. Despite financial challenges, the company secured FDA acceptance for its varegacestat NDA with a PDUFA …

TD Cowen Adjusts Price Target on Williams-Sonoma to $280 From $225, Keeps Buy Rating

TD Cowen has increased its price target for Williams-Sonoma (WSM) to $280 from $225, while maintaining a Buy rating on the stock. This adjustment reflects a positive outlook on the company's valuation.

Immunome (IMNM) widens losses as it funds oncology pipeline with $520M cash

Immunome (NASDAQ:IMNM) Releases Quarterly Earnings Results, Misses Estimates By $0.14 EPS

Immunome (NASDAQ:IMNM) announced its quarterly earnings, reporting a loss of $0.65 per share, which missed the consensus estimate by $0.14. Despite the earnings miss, the stock rose by $0.56 to $26.25, and analysts largely maintain a "Moderate Buy" rating with a $34.18 average price …

Form 8K NeoGenomics Inc For: 11 August By Investing.com

This article reports on NeoGenomics Inc.'s Form 8K filing for August 11th. The brief notice confirms the filing, and the article is primarily a placeholder for this regulatory update. No specific details about the content of the 8K filing are provided within this particular …

NeoGenomics announces planned departure of General Counsel Alicia Olivo

NeoGenomics, Inc. announced that Alicia Olivo, Executive Vice President, General Counsel, and Business Development, will depart from her role as General Counsel effective September 21, 2026, and will assist with the transition until October 2, 2026. This news follows the company's strong second-quarter 2026 …

Williams Sonoma EVP Karalyn Yearout sells $128,615 in stock

Karalyn Yearout, EVP and Chief Talent Officer at Williams-Sonoma Inc. (NASDAQ:WSM), sold 522 shares of company stock for $128,615 on August 7, 2026, as part of a pre-arranged trading plan. This transaction occurred while WSM stock was trading near its 52-week high, with InvestingPro …

Williams-Sonoma (NYSE:WSM) Hits New 12-Month High Following Analyst Upgrade

Williams-Sonoma (NYSE:WSM) reached a new 52-week high after Wells Fargo raised its price target and maintained an equal-weight rating. The company exceeded revenue and earnings estimates in its last quarterly report and announced a quarterly dividend. Analyst sentiment remains generally positive, despite the stock …

Metagenomi Records Wider Q2 Loss As MGX-001 Advanced Toward IND Submission

(RTTNews) - Metagenomi Therapeutics Inc. (MGX), an in vivo genome editing company, on Monday reported second quarter financial results, noting a higher loss owing to increased losses from operations and collaborations. The company specializes in in metagenomics - the study of genetic material from …

Williams-Sonoma stock hits all-time high at $253.46 USD

Williams-Sonoma stock has reached an all-time high of $253.46 USD, reflecting a 20.79% increase over the past year. The company's market capitalization is $29.5 billion, though an InvestingPro analysis suggests it may be overvalued. Recent developments include an "overweight" rating from Piper Sandler, a …

Has Williams-Sonoma (WSM) Run Too Far Ahead On Fresh Analyst Skepticism?

Recent bearish analyst calls on Williams-Sonoma (WSM) due to declining sales and valuation concerns are bringing the stock into focus, despite strong recent share price performance. While one narrative suggests WSM is 18% overvalued with a fair value of $212.63, another Simply Wall St …

Wells Fargo cuts Metagenomi stock price target on higher R&D costs

Wells Fargo has lowered its price target for Metagenomi Inc (NASDAQ:MGX) shares to $7.00 from $9.00, while maintaining an Overweight rating, citing higher-than-expected research and development expenses and a larger net loss per share in Q2 2026. Despite the stock trading down 24% year-to-date, …

Northcape Capital Pty Ltd Has $57.42 Million Position in Fomento Economico Mexicano S.A.B. de C.V. $FMX

Northcape Capital Pty Ltd reduced its stake in Fomento Economico Mexicano (FMX) by 9.1% in Q2, retaining 448,912 shares valued at $57.42 million, making it the fund's fifth-largest holding. FEMSA reported strong quarterly revenue and earnings, with institutional investors owning 61% of the stock. …

Wells Fargo Adjusts Price Target on Williams-Sonoma to $240 From $190, Maintains Equalweight Rating

Wells Fargo has increased its price target for Williams-Sonoma (WSM) to $240 from $190, while reiterating an "Equalweight" rating on the stock. This adjustment reflects an updated outlook on the home furnishings retailer. The news comes alongside other recent analyst target adjustments for Williams-Sonoma …

A Rural Utility Just Put Truck-Delivered Batteries Into Service

NOMAD Power Solutions (Nasdaq: NMAD), formerly LIXTE Biotechnology Holdings, has transitioned its primary focus to energy infrastructure, offering truck-transportable, utility-grade battery storage systems. These mobile units address the bottleneck in American electricity by providing flexible power solutions for various applications, including supporting utilities and …

10x Genomics (TXG): Doubled, Then Doubled Again

10x Genomics (TXG) has been a significant winner for Hedgeye, with its stock price soaring over 157% since May 19 due to strong Signal Strength, favorable macroeconomic "Quads," and robust fundamental performance. The company recently reported strong second-quarter results, raised full-year guidance, and despite …

IMNM Q1 2026 Earnings: Narrower Loss Beats Expectations, Shares Rise 2.64% - Quarterly Profit Report

Why Ajinomoto (TSE:2802) Is Up 7.7% After Raising Guidance On AI Materials Strength And Merger Plan

Fomento Económico Mexicano, S.A.B. de C.V. (0TD7.L) stock price, news, quote and history

This Yahoo Finance page provides a summary of Fomento Económico Mexicano, S.A.B. de C.V. (0TD7.L) stock information, including its current price, a news feed, and historical data. The stock is listed on the LSE and closed at 118.32 USD, down 2.03%. The news section …